Lates News

date
31/03/2026
Every AI Express, Dongwu Securities released a research report on March 31, giving a "buy" rating to Di'an Diagnostics (300244.SZ). The rating reasons mainly include: 1) Di'an Diagnostics is an innovative leader in the domestic medical diagnostic field; 2) The penetration rate of the ICL market is expected to increase, and industry consolidation is accelerating; 3) Policy support, AI+ promotes cost reduction and efficiency improvement in the ICL industry; 4) The company's "AI+data" promotes the new five-year strategic upgrade. (Daily Economic News)
Latest
See all latestmore